tirzepatide semaglutide peptide or small molecule Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology PDB-101: Molecule of the Month:
Description
Protecting muscle requires a full plan
This dehydration causes body tissues to shrink, putting pressure on pain receptors in the brain and triggering headaches
Well talk through why muscle loss matters during weight loss
Additionally, it improves blood sugar control, making it highly effective for individuals with type 2 diabetes
( B ) Representative images of mouse pancreas sections immunostained for GLP-1 (red), glucagon (green), and DAPI in WT and KO mice treated with saline (CTRL) or liraglutide (LIRA)
